血清hs-CRP CysC水平在缺血性脑卒中中的作用的研究进展

Research Progress on the Role of Serum hs-CRP and CysC Levels in Ischemic Stroke

本综述探讨了超敏C反应蛋白(hs-CRP)和胱抑素C (CysC)在缺血性脑卒中中的作用及其作为疾病预测标志物和治疗靶点的潜力。研究显示,hs-CRP作为炎症标志物,其水平升高与缺血性脑卒中风险增加、病情严重度及不良预后相关;CysC不仅反映肾功能,还在神经保护和脑卒中恢复中发挥作用,提示其在预测及治疗缺血性脑卒中中的潜在价值,强调了进一步研究这些生物标记物在缺血性脑卒中管理中应用的重要性。

This review discusses the roles of high-sensitivity C-reactive protein (hs-CRP) and Cystatin C (CysC) in ischemic stroke, as well as their potential as predictive biomarkers and therapeutic targets for the disease. Studies have shown that hs-CRP, as an inflammation marker, is associated with an increased risk of ischemic stroke, severity of the condition, and poor prognosis. CysC not only reflects kidney function but also plays a role in neuroprotection and stroke recovery, indicating its potential value in predicting and treating ischemic stroke. The importance of further research into the application of these biomarkers in the management of ischemic stroke is emphasized.